Dr Reddy's Plunges 9% After Weak Q1 Results as Global Supply Chain Woes Sink Profitability
Shares of Dr Reddy's tanked significantly on Thursday, falling 9% to ₹1,080 on the BSE. This sharp decline followed the announcement of a weak first-quarter performance for the financial year 2027. The company reported dips in both profitability and revenue, leading to intensified bearish outlook from several major brokerages.Financial Performance and Core Business Challenges
Dr Reddy's net profit stood at ₹443 crore, marking a severe 69% plunge during the quarter under review. Revenue from operations also saw a decline of 6%, reaching ₹8,071 crore compared to the same quarter last year.The company attributed part of its challenges to a...